Results 221 to 230 of about 4,481,103 (333)
Multi-level feature encoding algorithm based on FBPSI for heart sound classification. [PDF]
Fang Y, Leng H, Wang W, Liu D.
europepmc +1 more source
Optimal model‐based design of experiments for parameter precision: Supercritical extraction case
Abstract This study investigates the process of chamomile oil extraction from flowers. A parameter‐distributed model consisting of a set of partial differential equations is used to describe the governing mass transfer phenomena in a cylindrical packed bed with solid chamomile particles under supercritical conditions using carbon dioxide as a solvent ...
Oliwer Sliczniuk, Pekka Oinas
wiley +1 more source
Automated analysis of heart sound signals in screening for structural heart disease in children. [PDF]
Papunen I +11 more
europepmc +1 more source
Cinnamon (Cinnamomum spp.) is used as a culinary spice and dietary supplement. A major constituent, cinnamaldehyde, was previously shown to inactivate cytochrome P450 (CYP) 2A6 in vitro. A mechanistic static model predicted an ~5‐fold increase in the AUC of the CYP2A6 substrates nicotine and letrozole.
Aiden‐Hung P. Nguyen +8 more
wiley +1 more source
Enhanced heart sound anomaly detection via WCOS: a semi-supervised framework integrating wavelet, autoencoder and SVM. [PDF]
Zeng P, Kang S, Fan F, Liu J.
europepmc +1 more source
Traditionally, clinical outcomes measuring how a patient feels, functions, or survives are preferred endpoints in clinical trials; however, some may take a long time to manifest in slowly developing diseases. Biomarkers, if properly validated, can serve as surrogate endpoints, acting as substitutes for clinical outcomes.
Renske Johanna Grupstra +4 more
wiley +1 more source
Correlations between heart sound components and hemodynamic variables. [PDF]
Park YS +9 more
europepmc +1 more source
The Heart as an Ocean exploring meaningful interaction with biofeedback [PDF]
Correia da Silva Diniz, Nuno +3 more
core
Regional differences in approved drug dosages and administration are shaped by complex factors, including clinical data, prior regulatory decisions, and region‐specific considerations. This study investigated how such factors are associated with variations in approved doses across the United States Food and Drug Administration (FDA), European Medicines
Sachiko Mita, Shunsuke Ono
wiley +1 more source

